Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03176784 · ClinicalTrials.gov registry record · Phase 4
UW Quitting Using Intensive Treatment Study (QUITS)
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,251
- Enrollment target
NCT03176784 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 1,251 participants.
The verdict
NCT03176784, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,251 participants
- Enrollment target
Study Summary
This research will determine whether two highly promising modifications to varenicline treatment (i.e. use of a nicotine patch adjuvant and extended 24-week duration) produce superior smoking outcomes when they are either used together or alone. Despite their promise, the proposed modifications have never been experimentally evaluated relative to standard varenicline pharmacotherapy. Thus, this innovative research will produce novel evidence regarding how best to help smokers quit, and thereby address the leading cause of preventable mortality and morbidity related to cardiovascular and pulmonary diseases.
Interventions
- DRUG Varenicline
- DRUG Nicotine patch
- OTHER Placebo Patch
- OTHER Placebo Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,251 participants |
| Start Date | 2017-11-11 |
| Est. Completion | 2020-07-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03176784
The ClinicalTrials.gov registry entry for NCT03176784 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,251 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Varenicline is the first listed.
NCT03176784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03176784 about?
NCT03176784 is a clinical study titled "UW Quitting Using Intensive Treatment Study (QUITS)". This research will determine whether two highly promising modifications to varenicline treatment (i.e. use of a nicotine patch adjuvant and extended 24-week duration) produce superior smoking outcomes when they are either used together or alone. Despite their promise, the proposed modifications have...
What is the current status of trial NCT03176784?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,251 participants. The study started on 2017-11-11. Estimated completion is 2020-07-09.
What interventions are being tested in trial NCT03176784?
The interventions under investigation include: Varenicline (DRUG), Nicotine patch (DRUG), Placebo Patch (OTHER), Placebo Pill (OTHER).
Who is sponsoring clinical trial NCT03176784?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.